Move Active
Move Active, licence 80069888: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Move Active Once Daily Joint Support with UC-II
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80069888
- Status
- Inactive licence
- Licence date
- 2 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bromélaïne de tige Source : Bromélaïne de tige | 4.0 mg | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 84000.0 Unités de papaïne du FCC | Not calculated |
| Gallus gallus Source : Gallus gallus - cartilage Potency : 0.0 10 mg (36.8%) Collagen | 27.2 mg | Not calculated |
| Gallus gallus Source : Gallus gallus - cartilage Potency : 0.0 1.2-3.9 mg (4.4-14.3%) Unhydrolyzed collagen type II | Not specified | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) Extract : Matériel brut sec Extraction ratio : 2-5:1.0 Dry plant equivalent : 42-105 mg | 21.0 mg | Not calculated |
Non-medicinal ingredients
Chlorure de potassium, Gélatine, Cellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain and stiffness in person suffering from osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80069888
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.